OrbiMed
EHTH icon

OrbiMed’s eHealth EHTH Stock Holding History

OrbiMed’s Portfolio EHTH Stock Details EHTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-100,000
Closed -$6.68M – 139
2019
Q3 		$6.68M Buy
+100,000
New +$9.02M 0.13% 87

Other funds holding EHTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Starboard Value
Starboard Value New York $4.52B AUM 19.34% 1-Year Est. Return
Ruffer LLP
Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return
HEC
Hudson Executive Capital New York $50.9M AUM 22.11% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

OrbiMed's EHTH Position: Q1 2021 in Review

OrbiMed sold out of eHealth (EHTH) in Q1 2021, closing a stake of 844,046 shares — an estimated $59.6M sold.

OrbiMed first reported a position in EHTH in Q1 2015 and held it in 24 quarters. The position peaked at $107M in Q4 2019. 199 funds tracked by Wall St. Rank hold EHTH as of Q1 2021.

  • OrbiMed reported no remaining eHealth position as of Q1 2021 after selling out during the quarter.
  • OrbiMed sold 844,046 eHealth shares in Q1 2021, an estimated $59.6M.
  • OrbiMed first reported a position in eHealth in Q1 2015 and held it in 24 quarters.
  • OrbiMed's eHealth position peaked at $107M in Q4 2019.
  • 199 funds tracked by Wall St. Rank held eHealth as of Q1 2021.

Based on OrbiMed's 13F filing for Q1 2021, filed 17 May 2021.